世界のプロティンエンジニアリング（蛋白質工学）関連市場...市場調査レポートについてご紹介

Table Of Content
1 Introduction (Slide No. 18 – 23)
1.1 Key Take- Aways
1.2 Assumptions
1.3 Report Scope
1.4 Research Methodology
1.5 Key Data Points From Primary And Secondary Sources

2 Executive Summary (Slide No. 24 – 27)

3 Protein Engineering Technologies – Landscape Analysis (Slide No. 28 – 45)
3.1 Technology – Introduction
3.2 Technology – Evolution
3.3 Market Segmentation
3.4 Protein And Antibody Engineering Technologies – Overview
3.4.1 Sequence Modification
3.4.2 Glycosylation
3.4.3 Pegylation
3.4.4 Display Technologies
3.4.5 Humanization Technology
3.4.6 Hybrid Technology
3.4.7 Production Systems
3.4.8 Mapping Of Protein Production Systems
3.4.9 Emerging Production Systems
3.5 Protein Engineering – Technology Value Chain Analysis

4 Applications (Slide No. 46 – 54)
4.1 Therapeutic Development – Overview
4.1.1 Insulin Analogs
4.1.2 Monoclonal Antibodies
4.1.3 Therapeutic Development – Erythropoietin & Others
4.2 Diagnostics
4.3 Research – Meganuclease Engineering / ZFP & TALENS Engineering

5 Market Landscape Analysis (Slide No. 55 – 92)
5.1 Global Protein Engineering Market Forecast
5.1.1 Introduction
5.1.2 Global Market Forecast, By Geography
5.1.3 Global Market Forecast, By Product
5.1.4 Global Market Forecast, By Application
5.1.5 Global Market Forecast, By Technology
5.2 Market Dynamics – Overview
5.2.1 Drivers – Description
5.2.2 Drivers’ Impact – Timeline
5.2.3 Restraints – Description
5.2.4 Restraints Impact – Timeline
5.2.5 Opportunities – Description
5.2.6 Threats – Description
5.2.7 Pestle Analysis
5.3 Market Segmentation, By Product
5.3.1 Insulin Analogs
5.3.1.1 Insulin Analog Market
5.3.1.2 Insulin Analog Market, By Geography
5.3.1.3 Market Share Analysis
5.3.2 Modified EPO
5.3.2.1 Modified EPO Market
5.3.2.2 Modified EPO Market, By Geography
5.3.3 Monoclonal Antibodies (MAB)
5.3.3.1 Monoclonal Antibodies Market
5.3.3.2 Monoclonal Antibodies Market, By Geography
5.3.3.3 Monoclonal Antibodies Market, By Application
5.3.3.4 Major Products In The Market
5.4 Other Proteins
5.4.1 Other Proteins Market
5.4.2 Other Proteins Market, By Geography
5.4.3 Diagnostic Proteins, By Geography

6 Geographic Analysis (Slide No. 93 – 100)
6.1 North America
6.2 Europe
6.3 Asia
6.4 Row

7 Technology And Product Portfolio (Slide No. 101 – 105)
7.1 Proprietary Technology Platforms
7.2 Product Pipeline Analysis Of Key Players

8 Competitive Landscape (Slide No. 106 – 111)
8.1 Introduction
8.2 Porter’s Five Force Analysis
8.3 Mergers & Acquisitions, 2009 – 2012
8.4 Partnerships & Collaborations, 2012 – 2013
8.5 New Product Launch, 2010 – 2012

9 Analyst Insights And Recommendation (Slide No. 112 – 114)
9.1 Strategic Recommendations

10 Company Profiles (Slide No. 115 – 146)
10.1 Genentech, Inc.
10.2 Amgen, Inc.
10.3 Biogen Idec, Inc.
10.4 Novartis Ag
10.5 Glaxo Smithkline Plc
10.6 Eli Lilly & Co
10.7 Bristol Myers Squibb Co.
10.8 Johnson & Johnson
10.9 Merck & Co., Inc.
10.10 Sanofi
10.11 Pfizer, Inc.
10.12 Regeneron Pharmaceuticals, Inc.
10.13 Eleven Biotherapeutics (U.S.)
10.14 Toolgen, Inc. (Korea)
10.15 Dna2.0, Inc. (U.S.)
10.16 Avidbiotics Corp. (U.S.)
10.17 Sigma-Aldrich Corp. (U.S.)
10.18 Xencor Inc.
10.19 Morphosys